Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology

[1]  A. Berchuck,et al.  Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  L. Mack,et al.  Controversies in the management of metastatic melanoma to regional lymphatic basins , 2004, Journal of surgical oncology.

[3]  C. Pettaway,et al.  The role of lymphadenectomy in penile cancer. , 2004, Urologic oncology.

[4]  M. Maiman,et al.  A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study , 2004 .

[5]  M. J. Webb,et al.  Cytokeratin staining of resected lymph nodes may improve the sensitivity of surgical staging for endometrial cancer. , 2003, Gynecologic oncology.

[6]  J. Fanning Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy. , 2001, Gynecologic oncology.

[7]  M. Kawai,et al.  Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. , 2001, Gynecologic oncology.

[8]  M. J. Webb,et al.  Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? , 2000, American journal of obstetrics and gynecology.

[9]  G. Calais,et al.  Predictors of distant recurrence in clinical stage I or II endometrial carcinoma treated by combination surgical and radiation therapy. , 1997, Gynecologic oncology.

[10]  D. Gershenson,et al.  Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes. , 1995, Gynecologic oncology.

[11]  E. Partridge,et al.  Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. , 1995, Gynecologic oncology.

[12]  M. Tattersall,et al.  The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer , 1993, International Journal of Gynecologic Cancer.

[13]  R. Kurman,et al.  Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study , 1991 .

[14]  B. Goff,et al.  Assessment of depth of myometrial invasion in endometrial adenocarcinoma. , 1990, Gynecologic oncology.

[15]  B. Bundy,et al.  Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study , 1987, Cancer.